Company: IPCX
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-111009
Chunk: 9

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
 underwriters’
over-allotment is not exercised in full or in part, so that the number of Founder Shares collectively represents 25% of the Company’s
issued and outstanding shares upon the completion of the Initial Public Offering (excluding the Private Placement Units). As a result
of the full exercise of the over-allotment option by the underwriter, the 1,100,000 Founder Shares are no longer subject to forfeiture.

The registration statement for the Company’s
Initial Public Offering was declared effective on April 24, 2025. On April 28, 2025, the Company consummated the Initial Public Offering
of 25,300,000 units at $10.00 per unit (the “Public Units” and with respect to the ordinary shares included in the Public
Units, the “Public Shares”), which includes the full exercise of the underwriters’ over-allotment option of 3,300,000
Units (see Note 3), generating gross proceeds of $253,000,000. Each Public Unit consists of one Class A ordinary share and one right (the
“Public Rights”) to receive one-tenth of one Class A ordinary share upon the consummation of an initial business combination.

5

INFLECTION POINT ACQUISITION CORP. III

NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS

SEPTEMBER 30, 2025

(Unaudited)

Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 740,000 units (the “Private Placement Units” and together
with the Public Units, the “Units”), to the Sponsor and Cantor Fitzgerald & Co., the representative of the underwriters
(“Cantor”), at a price of $10.00 per unit, or $7,400,000 in the aggregate. Of the 740,000 Private Placement Units, the Sponsor
purchased 500,000 Private Placement Units and Cantor purchased 240,000 Private Placement Units.

Transaction costs amounted to $17,305,941, consisting
of $4,400,000 of cash underwriting fee, $12,045,000 of deferred underwriting fee, and $860,941 of other offering costs.

The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units,
although substantially all of the net proceeds